Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-31

Clinical Trial Update: Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children

View source ↗

Summary

This document reports a clinical follow-up study evaluating rituximab for nephrotic syndrome in children, currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituxan (rituximab)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Nephrotic Syndrome, Rituximab | Status: RECRUITING